A clinical Phase I safety trial of plasmid based gene therapy using BK channel hSlo cDNA has been completed for erectile dysfunction and a future clinical trial is planned for the treatment of patients with OAB [36], [37]. The gene discussed is KCNMA1; the disease is erectile dysfunction.